Price prediction
Regeneron Pharmaceuticals Price Prediction
Will Regeneron Pharmaceuticals (REGN) go up or down? Here is the Regeneron Pharmaceuticals price prediction and forecast for 2026, 2030, 2035 and 2040, combining AI price targets from Grok, ChatGPT and Claude, the Wall Street analyst consensus price target and rating, and a live community forecast. Opinions only, not financial advice.
Preview: sample forecasts shown while the live AI prediction feed is being wired up.
Regeneron Pharmaceuticals AI Price Prediction
Sample AI forecasts
Grok (xAI), ChatGPT (OpenAI) and Claude (Anthropic) give Regeneron Pharmaceuticals (REGN) a 2026 price target, averaging $813.00 (+22.3% versus the current price). Each model's reasoning is below; switch the horizon to see the REGN price prediction for 2026, 2030, 2035 and 2040.
Grok
xAI
End of 2026 target
$897.00 +35.0%
Grok leans bullish: momentum and REGN social volume are building near term, and it sees the long-run trend compounding higher.
ChatGPT
OpenAI
End of 2026 target
$811.00 +22.0%
ChatGPT expects a steady grind higher for REGN: constructive over time, with overhead resistance capping the near-term upside.
Claude
Anthropic
End of 2026 target
$731.00 +10.0%
Claude is cautious near term on stretched positioning, but turns constructive on REGN over multi-year horizons.
Regeneron Pharmaceuticals Analyst Forecast and Price Target
From the latest Wall Street analyst consensus
The Wall Street analyst price target and consensus rating for Regeneron Pharmaceuticals (REGN), currently $823.00, built from buy, hold and sell ratings and 12-month price targets.
Analyst consensus
Wall Street analysts
End of 2026 target
$823.00 +23.8%
Wall Street's 12-month consensus for REGN is 823 (+24% to target), from 16 analysts. Rolling that forward on analysts' own EPS estimates gives about 1,277 by 2030 (71.55 EPS at the consensus 18x multiple), held past 2030 beyond their coverage.
Regeneron Pharmaceuticals Community Price Prediction
Updates live as CFGI members vote and add targets
What the CFGI community forecasts for Regeneron Pharmaceuticals (REGN) by 2026, with a median REGN target of $813.00. Add your own Regeneron Pharmaceuticals price prediction and vote bullish, neutral or bearish below.
Community
CFGI voters
End of 2026 target
$813.00 +22.3%
Where the CFGI community is leaning for REGN: seeded from the AI average, then updated live as members vote and add price targets. Add yours below.
Add your forecast
Your call on Regeneron Pharmaceuticals by 2026?
2026Regeneron Pharmaceuticals Price Prediction 2026
By the end of 2026, the average Regeneron Pharmaceuticals (REGN) price prediction is $813.00 (+22% versus the current price), with targets ranging from a bearish $731.00 to a bullish $897.00. Near-term, it tracks earnings, rate expectations and the broader market. Switch the horizon above to compare each model's 2026 REGN target.
Regeneron Pharmaceuticals Price Prediction 2030
By the end of 2030, the average Regeneron Pharmaceuticals (REGN) price prediction is $1,374 (+107% versus the current price), with targets ranging from a bearish $1,130 to a bullish $1,728. A 2030 view leans on sustained earnings growth and is far less certain than the 2026 one. Switch the horizon above to compare each model's 2030 REGN target.
Regeneron Pharmaceuticals Price Prediction 2035
By the end of 2035, the average Regeneron Pharmaceuticals (REGN) price prediction is $2,237 (+237% versus the current price), with targets ranging from a bearish $1,277 to a bullish $2,990. By 2035 the range widens sharply, hinging on Regeneron Pharmaceuticals's role in the stock landscape a decade out. Switch the horizon above to compare each model's 2035 REGN target.
Regeneron Pharmaceuticals Price Prediction 2040
By the end of 2040, the average Regeneron Pharmaceuticals (REGN) price prediction is $3,123 (+370% versus the current price), with targets ranging from a bearish $1,277 to a bullish $4,319. A 2040 REGN target is highly speculative, a best-case scenario rather than a base-case forecast. Switch the horizon above to compare each model's 2040 REGN target.
How High Can Regeneron Pharmaceuticals Go?
The most bullish Regeneron Pharmaceuticals (REGN) forecast on this page is $3,123 by 2040, with the bull case for 2026 near $897.00. How high Regeneron Pharmaceuticals can actually go depends on earnings growth, valuation and the wider market, so treat the highest REGN targets as a best case, not a base case. For the downside, the most bearish 2026 forecast here is $731.00.
Will Regeneron Pharmaceuticals Go Up or Down?
Looking to the end of 2026, the AI models lean bullish on Regeneron Pharmaceuticals (REGN), with an average REGN target of $813.00. Whether Regeneron Pharmaceuticals goes up or down from here comes down to momentum, liquidity and macro conditions, and no forecast is certain. For a live read on whether the market is fearful or greedy on Regeneron Pharmaceuticals right now, see the Regeneron Pharmaceuticals Fear and Greed Index.
Is Regeneron Pharmaceuticals a Good Investment?
No price prediction can tell you whether Regeneron Pharmaceuticals (REGN) is a good investment. The targets on this page are opinions, and stock markets can move against even a strong consensus. What they do give you is a range: a bullish case near $897.00 and a bearish case near $731.00 for 2026, with a middle path between. Weigh that against your own time horizon and risk tolerance, and never invest more than you can afford to lose. This is not financial advice.
How Accurate Are Regeneron Pharmaceuticals Price Predictions?
No model or analyst can reliably predict the Regeneron Pharmaceuticals price, and accuracy falls the further out the forecast goes: a 2026 REGN target is far more grounded than a 2040 one. We log every AI and analyst forecast over time, so the Regeneron Pharmaceuticals prediction track record can be checked against what actually happened. Confidence scores show how strongly each model holds its view, not the probability of being right. Markets routinely defy forecasts, so use these as one input among many and never trade on a REGN prediction alone.
How Is the Regeneron Pharmaceuticals Price Prediction Calculated?
Each day we ask three leading AI models, Grok (xAI), ChatGPT (OpenAI) and Claude (Anthropic), for a Regeneron Pharmaceuticals (REGN) price target at every horizon, anchored to the live price. We pair that with the Wall Street analyst consensus price target and rating, and the community forecast adds a live member vote and median price target. Explore the rest of the Regeneron Pharmaceuticals data: the live REGN price, trading volume, price history and latest news, the stock market, and the Regeneron Pharmaceuticals Fear and Greed Index.
Frequently asked questions
What is the Regeneron Pharmaceuticals price prediction for 2026?
What is the Regeneron Pharmaceuticals price prediction for 2030?
Will Regeneron Pharmaceuticals go up?
Is Regeneron Pharmaceuticals a good investment?
How high can Regeneron Pharmaceuticals go?
Are AI Regeneron Pharmaceuticals price predictions accurate?
How are Regeneron Pharmaceuticals price predictions made?
These are AI and analyst opinions and a community poll, not financial advice. Price forecasts are frequently wrong and grow less certain the further out they go; never trade on them alone.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.